Autopsy report · NCT00208377

A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery

“DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all clinical studies for this product and decided to close this Study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 2 months after it had already started.
• Ran for about 7 years 5 months before it stopped.
• 228 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

DePuy International

Sponsor type

Industry

Conditions

Rheumatoid Arthritis; Osteoarthritis; Post-traumatic Arthritis; Collagen Disorders; Avascular Necrosis; Nonunion of Femoral Fractures

Interventions

DePuy ASR Hip System

Participants

228

Sites

3

Countries

Australia, Germany, United Kingdom

Trials that died the same way

• Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
  “Study discontinued due to futility.” (61% match in meaning)
• Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
  “the patients are now followed in another hospital. The study is discontinued” (61% match in meaning)
• A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
  “Study was prematurely discontinued due to unacceptable toxicity.” (60% match in meaning)
• Electroporation and Immunotherapy in Metastatic Colorectal Cancer
  “The study was terminated on the basis on an evaluation of the efficacy and safety of the 4 included and treated patients.” (60% match in meaning)
• RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
  “The sponsor's clinical program for the agent used in this study was discontinued.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.